Development of imipenem resistance in an Aeromonas veronii biovar sobria clinical isolate recovered from a patient with cholangitis

References

1. Abbott S. L., Cheung W. K. W., Janda J. M. 2003; The genus Aeromonas : biochemical characteristics, atypical reactions, and phenotypic identification schemes. J Clin Microbiol 41:2348–2357 [CrossRef]
   [Google Scholar]
2. Alksne L. E., Rasmussen B. A. 1997; Expression of the AsbA1, OXA-12, and AsbM1 beta-lactamases in Aeromonas jandaei AER 14 is coordinated by a two-component regulon. J Bacteriol 179:2006–2013
   [Google Scholar]
3. Clark N. M., Chenoweth C. E. 2003; Aeromonas infection of the hepatobiliary system: report of 15 cases and review of the literature. Clin Infect Dis 37:506–513 [CrossRef]
   [Google Scholar]
4. Clinical and Laboratory Standards Institute 2006 Performance Standards for Antimicrobial Susceptibility Testing ; 16th Informational Supplement M100S16 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
5. Figueras M. J. 2005; Clinical relevance of Aeromonas . Rev Med Microbiol 16:145–153 [CrossRef]
   [Google Scholar]
6. Figueras M. J., Guarro J., Martínez-Murcia A. J. 2000a; Clinically relevant Aeromonas species. Clin Infect Dis 30:988–989
   [Google Scholar]
7. Figueras M. J., Soler L., Chacón M. R., Guarro J., Martinez-Murcia A. J. 2000b; Extended method for discrimination of Aeromonas spp. by 16S rDNA RFLP analysis. Int J Syst Evol Microbiol 50:2069–2073 [CrossRef]
   [Google Scholar]
8. Gallardo F., Ruiz J., Marco F., Towner K. J., Vila J. 1999; Increase in incidence of resistance to ampicillin, chloramphenicol and trimethoprim in clinical isolates of Salmonella serotype Typhimurium with investigation of molecular epidemiology and mechanisms of resistance. J Med Microbiol 48:367–374 [CrossRef]
   [Google Scholar]
9. Hernandez Valladares M., Kiefer M., Heinz U., Soto R. P., Meyer-Klaucke W., Nolting H. F., Zeppezauer M., Galleni M., Frere J. M. other authors 2000; Kinetic and spectroscopic characterization of native and metal-substituted β -lactamase from Aeromonas hydrophila . FEBS Lett 467:221–225 [CrossRef]
   [Google Scholar]
10. Janda J. M., Abbot S. L. 1998; Evolving concepts regarding the genus Aeromonas : an expanding panorama of species, disease presentations, and unanswered questions. Clin Infect Dis 27:332–334 [CrossRef]
    [Google Scholar]
11. Ko W. C., Yu K. W., Liu C. Y., Huang C. T., Leu H. S., Chuang Y. C. 1996; Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan. Antimicrob Agents Chemother 40:1260–1262
    [Google Scholar]
12. Ko W. C., Wu H. M., Chang T. C., Yan J. J., Wu J. J. 1998; Inducible β lactam resistance in Aeromonas hydrophila : therapeutic challenge for antimicrobial therapy. J Clin Microbiol 36:3188–3192
    [Google Scholar]
13. Ko W. C., Chiang S. R., Lee H. C., Tang H. J., Wang Y. Y., Chuang Y. C. 2003; In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila . Antimicrob Agents Chemother 47:2217–2222 [CrossRef]
    [Google Scholar]
14. Koehler J. M., Ashdown L. R. 1993; In vitro susceptibilities of tropical strains of Aeromonas species from Queensland, Australia, to 22 antimicrobial agents. Antimicrob Agents Chemother 37:905–907 [CrossRef]
    [Google Scholar]
15. Maluping R. P., Lavilla-Pitogo C. R., DePaola A., Janda J. M., Krovacek K., Greko C. 2005; Antimicrobial susceptibility of Aeromonas spp., Vibrio spp. and Plesiomonas shigelloides isolated in the Philippines and Thailand. Int J Antimicrob Agents 25:348–350 [CrossRef]
    [Google Scholar]
16. Mencacci A., Cenci E., Mazzolla R., Farinelli S., D'Alo F., Vitali M., Bistoni F. 2003; Aeromonas veronii biovar veronii septicaemia and acute suppurative cholangitis in a patient with hepatitis B. J Med Microbiol 52:727–730 [CrossRef]
    [Google Scholar]
17. Ouderkirk J. P., Bekhor D., Turett G. S., Murali R. 2004; Aeromonas meningitis complicating medicinal leech therapy. Clin Infect Dis 38:e36–e37 [CrossRef]
    [Google Scholar]
18. Rossolini G. M., Walsh T., Amicosante G. 1996; The Aeromonas metallo-beta-lactamases: genetics, enzymology, and contribution to drug resistance. Microb Drug Resist 2:245–252 [CrossRef]
    [Google Scholar]
19. Ruiz M., Martí S., Fernandez-Cuenca F., Pascual A., Vila J. 2007; High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect 13:1192–1198 [CrossRef]
    [Google Scholar]
20. Sader H. S., Jones R. N. 2005; Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents 25:95–109 [CrossRef]
    [Google Scholar]
21. Shiina Y., Ii K., Iwanaga M. 2004; An Aeromonas veronii biovar sobria infection with disseminated intravascular gas production. J Infect Chemother 10:37–41 [CrossRef]
    [Google Scholar]
22. Soler L., Figueras M. J., Chacón M. R., Guarro J., Martinez-Murcia A. J. 2003; Comparison of three molecular methods for typing Aeromonas popoffii isolates. Antonie van Leeuwenhoek 83:341–349 [CrossRef]
    [Google Scholar]
23. Stunt R. A., Amyes A. K., Thomson C. J., Payne D. J., Amyes S. G. 1998; The production of a novel carbapenem-hydrolysing beta-lactamase in Aeromonas veronii biovar sobria, and its association with imipenem resistance. J Antimicrob Chemother 42:835–836 [CrossRef]
    [Google Scholar]
24. Tsai M. S., Kuo C. Y., Wang M. C., Wu H. C., Chien C. C., Liu J. W. 2006; Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. J Microbiol Immunol Infect 39:150–154
    [Google Scholar]
25. Vila J., Marco F., Soler L., Chacon M., Figueras M. J. 2002; In vitro antimicrobial susceptibility of clinical isolates of Aeromonas caviae , Aeromonas hydrophila and Aeromonas veronii biotype sobria. J Antimicrob Chemother 49:701–702 [CrossRef]
    [Google Scholar]
26. Vila J., Ruiz J., Gallardo F., Martha V., Lara S., Figueras M. J., Gascon J. 2003; Aeromonas spp. and traveler's diarrhea: clinical features and antimicrobial resistance. Emerg Infect Dis 9:552–555 [CrossRef]
    [Google Scholar]
27. Walsh T. R., Payne D. J., MacGowan A. P., Bennett P. M. 1995; A clinical isolate of Aeromonas sobria with three chromosomally mediated inducible β -lactamases: a cephalosporinase, a penicillinase and a third enzyme, displaying carbapenemase activity. J Antimicrob Chemother 35:271–279 [CrossRef]
    [Google Scholar]
28. Walsh T. R., Gamblin S., Emery D. C., MacGowan A. P., Bennett P. M. 1996; Enzyme kinetics and biochemical analysis of ImiS, the metallo- β -lactamase from Aeromonas sobria 163a. J Antimicrob Chemother 37:423–431 [CrossRef]
    [Google Scholar]
29. Walsh T. R., Neville W. A., Haran M. H., Tolson D., Payne D. J., Walsh T. R., Stunt R. A., Nabi J. A., MacGowan A. P., Bennett P. M. 1997; Distribution and expression of beta-lactamase genes among Aeromonas spp. J Antimicrob Chemother 40:171–178 [CrossRef]
    [Google Scholar]
30. Walsh T. R., Neville W. A., Haran M. H., Tolson D., Payne D. J., Bateson J. H., MacGowan A. P., Bennett P. M. 1998; Nucleotide and amino acid sequences of the metallo- β -lactamase, ImiS, from Aeromonas veronii bv. sobria. Antimicrob Agents Chemother 42:436–439
    [Google Scholar]